Skip to main content
OpenTrials
Completed

NCT Number: NCT01823627

Pulmonary Disease in a Psychiatric Inpatient Population

Purpose: Patients with mental health disorders have a reduced life expectancy, compared to the general population. The shorter life expectancy is caused by natural and unnatural death. In general, patients with a mental disorder tend to have a more unhealthy lifestyle, than the general population, characterized by e.g. lack of exercise and smoking.

Hypothesis

Chronic obstructive pulmonary disease (COPD) is underdiagnosed in psychiatric inpatients There is a higher prevalence of COPD in psychiatric inpatients compared to the general population Screening of patients with one respiratory symptom and a smoking history, has the same sensitivity regarding to diagnosis of COPD, as screening all patients with a smoking history

Method:

80 psychiatric inpatients will undergo spirometry with reversibility test and COPD Assessment Test (CATest). Furthermore, patient history regarding respiratory symptoms and smoking will be taken into account.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Obstructive Airway Disease Behavior Chronic Disease Disease Attributes Lung Diseases Lung Diseases, Obstructive Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases Smoking

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Psyciatrien Syd, Region Zealand

Vordingborg, 4760, Denmark

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Inpatients in Psykiatrien Syd, Region Zealand, ward S1,S2,S3,S4,S5,S6
  • Admission time over 48 hours

Exclusion criteria

  • Patients who is not able to perform spirometry due to their psychiatric condition

Treatment and study plan

Spirometry with reversibility test

Procedure

Spirometry with reversibility test and CATest questionaire. following will be measured FEV1 L/s FVC L/s FEV1/FVC ration

Other names: MicroLoop handheld transportable spirometer

Primary outcomes

  1. Tiffeneau index

    Time frame: at enrollment

    • FEV1/FVC ratio

Secondary outcomes

  1. forced vital capacity

    Time frame: at enrollment

    FVC L/s

  2. Forced expiratory volume in 1 second

    Time frame: at enrollment

    FEV1 L

Sponsors and collaborators

Lead sponsor

Psykiatrien Syd

Other

Collaborators

  • Naestved Hospital

Registry information

Official study title

Pulmonary Disease in a Psychiatric Inpatient Population, a Screening Study

Important dates

Study start
2013
Primary completion
2013
Study completion
2013
First posted
Apr 4, 2013
Registry last updated
May 24, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.